Offer - Urjas Oil for just ₹ 1 X
Tolnacomb (Surmuont) is an allopathic medicine The correct dosage of Tolnacomb (Surmuont) depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Tolnacomb (Surmuont) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Tolnacomb (Surmuont) safe for pregnant women?
Tolnacomb (Surmuont) shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Tolnacomb (Surmuont) safe during breastfeeding?
Tolnacomb (Surmuont) is completely safe for breastfeeding women.
What is the effect of Tolnacomb (Surmuont) on the Kidneys?
Very few cases of side effects of Tolnacomb (Surmuont) on kidney have been reported.
What is the effect of Tolnacomb (Surmuont) on the Liver?
Tolnacomb (Surmuont) does not damage the liver.
What is the effect of Tolnacomb (Surmuont) on the Heart?
Tolnacomb (Surmuont) is not harmful for the heart.
Tolnacomb (Surmuont) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Tolnacomb (Surmuont) unless your doctor advises you to do so -
Is this Tolnacomb (Surmuont) habit forming or addictive?
Tolnacomb (Surmuont) does not cause addiction.
Interaction between Food and Tolnacomb (Surmuont)
Taking Tolnacomb (Surmuont) with food does not harm your health.
Interaction between Alcohol and Tolnacomb (Surmuont)
Information about the interaction of Tolnacomb (Surmuont) and alcohol is not currently available because this topic has not been researched yet.
No, Tolnacomb (Surmuont) is a prescription drug so do not take it without consulting a doctor. It can be harmful to the patient to take this medicine without a doctor's recommendation because Tolnacomb (Surmuont) suppresses the immune system which lowers the immunity that can lead to infection to the patient. Hence patient should seek doctors advice before taking this medication by himself.
Yes, Tolnacomb (Surmuont) can be taken with an antibiotic. Taking Tolnacomb (Surmuont) with a certain antibiotic (Clarithromycin) can treat H.Pylori associated stomach infection. However, it is best to consult your doctor before taking these two medicines together.
Yes, Tolnacomb (Surmuont) can cause stomach upset. It is a common side effect of this drug but the exact reason of stomach cramp is not known. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Tolnacomb (Surmuont) is a brand name of betamethasone. It is a prescription drug that belongs to the class of medicine called steroids (corticosteroid). It comes in form of tablet, solution, injection and topical cream. It has potent anti-inflammatory properties. Tolnacomb (Surmuont) is used in the treatment of inflammatory joint diseases, multiple sclerosis, inflammation, allergic conditions, and adrenal insufficiency. It is also used to diagnose Cushing's syndrome.
No, Tolnacomb (Surmuont) Should not be stopped or discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine. Suddenly stopping Tolnacomb (Surmuont) can cause withdrawal symptoms such as fever, joint pain, and feeling of discomfort. To avoid the withdrawal symptoms, the dosage of this drug should be reduced gradually. Please consult your doctor if you are experiencing any withdrawal symptoms after stopping/discounting it on your own.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 362-370
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 289
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Celestone® (betamethasone)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Cortival (betamethasone valerate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Diprosone® Ov (betamethasone dipropionate)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gentamicin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 747-748